Andrew Sinclair's Net Worth

$334 Thousand

Estimate Recalculated Jun 18, 2025 08:31PM EST

Who is Andrew Sinclair

Andrew Sinclair does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Verona Pharma plc, Adicet Bio, Inc., Sierra Oncology, Inc., and SOLENO THERAPEUTICS INC.

SEC CIK

Andrew Sinclair's CIK is 0001762451

Past Insider Trading and Trends

2023 was Andrew Sinclair's most active year for acquiring shares with 9 total transactions. Andrew Sinclair's most active month to acquire stocks was the month of May. 2023 was Andrew Sinclair's most active year for disposing of shares, totalling 5 transactions. Andrew Sinclair's most active month to dispose stocks was the month of July. 2021 saw Andrew Sinclair paying a total of $0.00 for 226,190 shares, this is the most they've acquired in one year. In 2023 Andrew Sinclair cashed out on 100,400 shares for a total of $0.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Verona Pharma plc

Investor
Updated Aug 10, 2021
Form 4
64.00K
Aug 10, 2021
64.00K
Grant
Aug 09
Form 3/A
Jan 05, 2021
19.66M
Form 3
Jan 04, 2021
Showing 3 results

Adicet Bio, Inc.

Investor
Updated Aug 23, 2024
Form 4
Aug 23, 2024
100.40K
Acq/Dis
Aug 21
Form 4
547.46%
32.30K
Jun 07, 2024
38.20K
Grant
Jun 05
Form 4
Aug 16, 2023
100.40K
Acq/Dis
Aug 14
Form 4
32.30K
Jun 02, 2023
2.15M
Grant
Jun 01
Form 4
18.50K
Jun 03, 2022
18.50K
Grant
Jun 02
Form 4/A
30.95%
500.00K
$14.00
$7.00M
Dec 13, 2021
2.12M
Purchase
Dec 08
Form 4
30.47%
500.00K
$14.00
$7.00M
Dec 10, 2021
2.14M
Purchase
Dec 08
Form 4
26.67K
May 04, 2021
26.67K
Grant
Apr 30
Form 4/A
28.83K
Mar 16, 2021
1.64M
Grant
Mar 02
Form 3/A
Mar 16, 2021
1.62M
Form 4
28.83K
Mar 04, 2021
1.67M
Grant
Mar 02
Form 3
Mar 04, 2021
1.64M
Showing 12 results

Sierra Oncology, Inc.

Investor
Updated Jul 01, 2022
Form 4
-100.00%
-2.20M
$50.49
-$112.33M
Jul 01, 2022
Disposition
Jul 01
Form 4
12.89%
150.00K
$17.93
$7.84M
Feb 01, 2022
1.31M
Purchase
Jan 28 - Jan 31
Form 4
6.00K
Jun 09, 2021
6.00K
Grant
Jun 08
Form 4
6.87K
Jun 10, 2020
6.87K
Grant
Jun 09
Form 4/A
5,082.41%
859.74K
Feb 03, 2020
876.66K
Options
Jan 29
Form 4
5,081.43%
859.63K
Jan 31, 2020
876.54K
Options
Jan 29
Form 4
60.00K
Dec 03, 2019
60.00K
Grant
Nov 29
Form 3
Nov 26, 2019
216.67K
Showing 8 results

SOLENO THERAPEUTICS INC

Investor
Updated Jun 10, 2024
Form 4
6.50K
Jun 10, 2024
6.50K
Grant
Jun 06
Form 4
12.67K
May 26, 2023
12.67K
Grant
May 25 - May 26
Form 4
Oct 14, 2022
10.25K
Form 4
2.67K
Oct 14, 2022
2.67K
Grant
Jun 01
Form 4
149.87%
15.44M
Mar 31, 2022
25.74M
Purchase
Mar 29
Form 4
31.86K
Jun 04, 2021
31.86K
Grant
Jun 01
Form 4
40.00K
Jan 12, 2021
40.00K
Grant
Jan 08
Form 4
47.83%
3.33M
$1.65
$5.50M
Jul 06, 2020
10.30M
Purchase
Jun 26
Form 4
9.53K
May 20, 2020
9.53K
Grant
May 18
Form 4
49.26%
2.30M
$1.20
$2.76M
Oct 29, 2019
6.97M
Purchase
Oct 25
Form 4
13.00K
Jun 12, 2019
13.00K
Grant
Jun 10
Form 4
9.36M
$0.81
$7.50M
Dec 27, 2018
9.36M
Purchase
Dec 21
Form 3
Dec 27, 2018
Showing 13 results